Back
AbCellera Biologics Vs. InMed Pharmaceuticals Industry Stock Comparison
Sell
50
ABCL
AbCellera Biologics
Last Price:
3.78
Seasonality Move:
0.41%
Sell
17
INM
InMed Pharmaceuticals
Last Price:
0.26
Seasonality Move:
-31.59%
Sell
50
AbCellera Biologics (ABCL)
is a Sell
Is AbCellera Biologics a Buy, Sell or Hold?
- The current AbCellera Biologics [ABCL] share price is $3.78. The Score for ABCL is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- ABCL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
17
InMed Pharmaceuticals (INM)
is a Sell
Is InMed Pharmaceuticals a Buy, Sell or Hold?
- The current InMed Pharmaceuticals [INM] share price is $0.26. The Score for INM is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- INM is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
ABCL Stock Price Chart
What is AbCellera Biologics's stock price today?
-
The AbCellera Biologics share price today is $3.78
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABCL is experiencing slight selling pressure.
INM Stock Price Chart
What is InMed Pharmaceuticals's stock price today?
-
The InMed Pharmaceuticals share price today is $0.26
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INM is experiencing slight selling pressure.
ABCL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.22 | Sell |
| Relative Strength Index (14 RSI): | 36.1 | Sell |
| Chaikin Money Flow: | -354405 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.86 - 4.46) | Sell |
| Bollinger Bands (100): | (4.36 - 5.5) | Sell |
INM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 39.31 | Sell |
| Chaikin Money Flow: | -84719 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.27 - 0.35) | Sell |
| Bollinger Bands (100): | (0.31 - 0.39) | Sell |
ABCL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.84 | Sell |
| 20-day SMA: | 4.09 | Sell |
| 50-day SMA: | 4.49 | Sell |
| 200-day SMA: | 5.06 | Sell |
| 8-day EMA: | 3.84 | Sell |
| 20-day EMA: | 4.04 | Sell |
| 50-day EMA: | 4.4 | Sell |
| 200-day EMA: | 5.32 | Sell |
INM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.26 | Sell |
| 20-day SMA: | 0.3 | Sell |
| 50-day SMA: | 0.34 | Sell |
| 200-day SMA: | 0.54 | Sell |
| 8-day EMA: | 0.26 | Sell |
| 20-day EMA: | 0.29 | Sell |
| 50-day EMA: | 0.33 | Sell |
| 200-day EMA: | 0.95 | Sell |
AbCellera Biologics Earnings Growth & ABCL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.03 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.05 per share.
InMed Pharmaceuticals Earnings Growth & INM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
AbCellera Biologics Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
InMed Pharmaceuticals Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||